A randomized, double-blind study evaluating the safety and efficacy of etanercept and sulphasalazine in subjects with ankylosing spondylitis

Trial Profile

A randomized, double-blind study evaluating the safety and efficacy of etanercept and sulphasalazine in subjects with ankylosing spondylitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Sep 2014

At a glance

  • Drugs Etanercept (Primary) ; Sulfasalazine (Primary)
  • Indications Ankylosing spondylitis
  • Focus Therapeutic Use
  • Acronyms ASCEND
  • Sponsors Wyeth
  • Most Recent Events

    • 09 Nov 2012 Planned number of patients changed from 525 to 540. (Parent trial: EudraCT2005-001549-41).
    • 09 Nov 2012 Planned number of patients changed from 525 to 540. (Parent trial: EudraCT2005-001549-41).
    • 09 Apr 2012 Actual patient number for the extension trial (NCT00410046) is now 84.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top